We integrate technologies to reverse the pathology of pulmonary hypertension and other diseases
Research
We seek to uncover molecular pathways that lead to developmental and inflammatory mechanisms of vascular pathobiology, particularly pulmonary hypertension.
Our Team
Dr. Rabinovitch is proud to lead a team of talented individuals working together to advance cardiopulmonary research.
Publications
Publications stemming from our laboratory.
Helpful Links
Links to Stanford and external affiliates/resources
News & Highlights
Dr. Marlene Rabinovitch is the recipient of the prestigious American Heart Association 2023 Research Achievement Award
Dr. Lingli Wang on stopping pulmonary arterial hypertension progression
Dr. Shalina Taylor on Immune Reaction Gone Awry Causes Pulmonary Arterial Hypertension
Dr. Jan-Renier Moonen on the endothelial enhancer landscape under laminar shear stress
Upcoming Events
OPEN TO THE PUBLIC:
Events at the Stanford Cardiovascular Institute (CVI)
http://med.stanford.edu/cvi.html
Frontiers in Cardiovascular Science seminars
http://med.stanford.edu/cvi/mission/frontiers-in-cv-science.html
Pulmonary Hypertension Grand Rounds
http://med.stanford.edu/wallcenter/education/lectures.html
Annual Race Against PH
http://med.stanford.edu/raceagainstph.html
FOR STANFORD RESIDENTS/STUDENTS:
Cadiovascular Courses
http://med.stanford.edu/cvi/education/cvi-courses.html
If you are interested in joining our program as a Postdoctoral or Visiting Scholar, please contact Michelle Ameri.